XML 13 R4.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Income Statement [Abstract]    
Technology development and licensing revenue $ 125,000 $ 125,000
Operating expenses:    
Research and development 3,095,420 2,571,573
General and administrative 2,871,557 2,936,771
Total operating expenses 5,966,977 5,508,344
Loss from operations (5,841,977) (5,383,344)
Other income (expense):    
Loss from change in valuation of earn-out milestone liability (151,000)
Investment income 12,104 2,411
Interest expense on preferred stock (4,551,567)
Interest expense on loan facility (94,690) (157,614)
Other income 1,798 544
Total other income (expense), net (4,632,355) (305,659)
Net loss $ (10,474,332) $ (5,689,003)
Net loss per common share    
Basic and diluted $ (1.82) $ (3.31)
Weighted average shares outstanding    
Basic and diluted 5,770,467 1,720,290